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Estrogen receptor  (ER-) is a nuclear hormone receptor
that controls selected genes, thereby regulating proliferation
and differentiation of target tissues, such as breast. Gene ex-
pression controlled by ER- is modulated by Ca2 via calmod-
ulin (CaM). Here we present the NMR structure of Ca2-CaM
bound to two molecules of ER- (residues 287–305). The two
lobes of CaM bind to the same site on two separate ER-mole-
cules (residues 292, 296, 299, 302, and 303), which explains why
CaM binds two molecules of ER- in a 1:2 complex and stabi-
lizes ER- dimerization. Exposed glutamate residues in CaM
(Glu-11, Glu-14, Glu-84, and Glu-87) form salt bridges with key
lysine residues inER- (Lys-299, Lys-302, andLys-303),which is
likely to prevent ubiquitination at these sites and inhibit degra-
dation of ER-. Transfection of cells with full-length CaM
slightly increased the ability of estrogen to enhance transcrip-
tional activation by ER- of endogenous estrogen-responsive
genes. By contrast, expression of either the N- or C-lobe of CaM
abrogated estrogen-stimulated transcription of the estrogen
responsive genes pS2 and progesterone receptor. These data
suggest that CaM-induced dimerization of ER- is required for
estrogen-stimulated transcriptional activation by the recep-
tor. In light of the critical role of ER- in breast carcinoma,
our data suggest that small molecules that selectively disrupt
the interaction of ER- with CaM may be useful in the ther-
apy of breast carcinoma.
Estrogens exert pleiotropic functions in humans, ranging
from neuroprotection and prevention of osteoporosis to car-
dioprotection and growth of breast tissue (1). These effects are
produced through twomembers of the nuclear receptor super-
family, estrogen receptor- (ER-)4 and ER- (2). The recep-
tors share distinct structural and functional domains. These
are the A/B regions, which contain a transactivation domain
(AF1), the C region, which corresponds to the DNA-binding
domain, the D region containing the hinge domain, and the E/F
regions in which the ligand binding domain is located (2). Bind-
ing of 17-estradiol (E2) to ER- elicits effects in target tissues
via the “classic” pathway or by non-genomic signaling through
activation of protein kinase cascades (2, 3). In the classic signal-
ing mechanism, E2 induces a conformational change in ER-,
which then dimerizes. The E2-bound receptor translocates to
the nucleus where it binds to DNA at estrogen response ele-
ments (EREs) and recruits co-regulatory proteins. These co-ac-
tivators and co-repressors modulate the transcriptional activa-
tion of genes by ER-. A substantial body of evidence implicates
perturbation of E2 signaling in cancer initiation, progression,
and response to therapy (2). Although best characterized in
breast cancer, ER also contributes to carcinoma of the endome-
trium and prostate. A clear understanding of the molecular
mechanismof ER- signaling is required to develop better ther-
apeutic modalities for these neoplasms.
Recent data indicate that numerous proteins influence the
structure and function of ER-, stabilize the ER-/DNA inter-
action, and modulate gene expression (4). These proteins are
involved in cell cycle regulation, chromatin remodeling, protein
turnover, and cell migration. Accumulating evidence shows
that a group of ER-modifying proteins participate in cell sig-
naling. For example, the scaffold protein IQGAP1, which inte-
grates diverse signaling pathways (5, 6), binds ER- and modu-
lates its transcriptional function (7).
Another signaling protein that influences ER- is the Ca2
modulator calmodulin (CaM). CaM is a highly conserved pro-
tein that contains 148 amino acids. Via direct interactions with
numerous diverse proteins, CaM regulates several cellular
functions including growth, proliferation, and cell cycle pro-
gression (8). CaM binds directly to ER-, but not to ER- (9,
10), in a Ca2-regulated manner (11, 12). This interaction reg-
ulates the degradation of ER- via the ubiquitin-proteasome
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pathway (13) and is also required for normal transcriptional
function of ER- (14). To gain insight into themolecularmech-
anism by which CaM produces these effects, we recently con-
ducted structural analysis and solved theNMR structures of the
individual lobes of CaM (N- andC-lobes) each bound to a func-
tional fragment of ER- (residues 287–305) (15). Shortly there-
after, Leclercq and colleagues (16) published a manuscript in
which they analyzed the interaction of CaM with peptides cor-
responding to amino acid residues 287–311 and 295–311 of
ER-. These studies yielded two distinct models to describe the
interaction between CaM and ER- (15, 16). Our data revealed
that one CaM molecule binds two molecules of ER- in a 1:2
complex (15).We generated amodel inwhich each lobe of CaM
is attached to a separate hinge domain of ER-, suggesting that
CaM can facilitate dimerization of ER-. By contrast, Carlier et
al. (16) put forward a scheme in which the two lobes of CaM
interact allosterically and CaM undergoes a concerted confor-
mational change when binding ER-. To reconcile these con-
flicting models and determine the correct mode of binding, we
analyzed the structure of full-length CaM bound to two ER-
peptides. The data presented here reveal that this structure is
identical to the structures of the separate CaM lobes each
bound to ER-. Thus, the two ER- binding sites on CaM are
completely independent. In addition, analysis of ER- tran-
scriptional activity in human cells transfected with separate
lobes of CaMprovides in vivo evidence that bolsters ourmodel.
Results
NMR Structure of Full-length CaM Bound to Two Molecules
of ER-—Previously we solved NMR structures of individual
CaM lobes (CaM-N and CaM-C) each bound to a peptide frag-
ment of ER- (residues 287–305, called ER(287–305)) (15). The
N-terminal half (CaM-N, amino acids 1–74) and the C-termi-
nal half (CaM-C, amino acids 75–148) of calmodulin each
bound to one ER- with nearly the same affinity as full-length
CaM (CaM-F) binds to two ER- (15). Thus, the twoCaM lobes
bind independently to two separate ER-molecules, suggesting
that CaM may stabilize dimerization of ER-. In the current
study, we present a NMR structural analysis of full-length CaM
bound to two molecules of ER(287–305). The 1H-15N HSQC
spectrum of 15N-labeled CaM bound to two molecules of
ER(287–305) (Fig. 1A) looks similar to the NMR spectra of
CaM-N (cyan in Fig. 1A) and CaM-C (magenta in Fig. 1A) each
bound to onemolecule of ER(287–305). This spectral similarity
demonstrates that in the full-length protein bothCaM lobes are
independently folded and each lobe binds independently to a
separate ER- molecule. The constant time 1H-13C HSQC
spectrum of 13C-labeled CaM bound to two molecules of unla-
beled ER(287–305) also matches quite well to both spectra of
the individual lobes (Fig. 1B). The agreement of the methyl
chemical shifts in 1H-13C HSQC spectra (of CaM-F versus
CaM-N and CaM-C) demonstrates that the structural environ-
ment of side chain methyl groups in the exposed hydrophobic
core of both lobes that contact ER(287–305) must be
unchanged in full-length CaM. Therefore, the structure of the
individual lobes bound to ER- determined previously (15)
must have a similar structure in full-length CaM bound to two
ER- molecules. To further test this hypothesis, we solved the
NMR structure of full-length CaM bound to two ER(287–305)
molecules.
AnNMR-derived structuralmodel of full-lengthCaMbound
to two molecules of ER(287–305) is shown in Fig. 2. Three-
dimensional protein structures derived from the NMR assign-
ments were calculated on the basis of NOE data, chemical shift
analysis, 3JNH spin-spin coupling constants, and residual dipo-
lar coupling restraints as described previously (15) (see “Exper-
imental Procedures”). Table 1 summarizes the structural statis-
tics calculated for the 10 lowest energy conformers.
The main chain structure of the N-lobe in full-length CaM
bound to ER(287–305) looks quite similar to the structure of
CaM-N bound to ER(287–305) (15). The root mean square
deviation is 0.6 Å when comparing the main chain atoms of
the full-length CaMN-lobe versusCaM-N. The EF-hand inter-
helical angles for the full-length CaM N-lobe (bound to
ER(287–305) are 84° for EF1 and 90° for EF2, which are lower
than those for free CaM (EF1, 103.8° and EF2, 101°). Exposed
hydrophobic side chains in the full-length CaM N-lobe (Met-
51, Val-55, Ile-63, and Met-72) interact with the aromatic side
chain of Trp-292 from ER(287–305) (Fig. 2B). Also noteworthy
are exposed glutamate side chains in full-length CaM N-lobe
(Glu-11 and Glu-14) that form salt bridges with lysine residues
in ER- (Lys-299 and Lys-303).
The main chain structure of the C-lobe in full-length CaM
bound to ER(287–305) (Fig. 2) looks similar to the structure of
CaM-C bound to ER(287–305) (15). The root mean square
deviation is 0.8 Å when comparing the main chain atoms of
the full-length CaM C-lobe versus CaM-C. The EF-hand inter-
helical angles for the full-length CaM C-lobe bound to ER-
(103 °C for EF3 and 94 °C for EF4) are close to those for free
CaM. Exposed hydrophobic residues in CaM (Ile-100, Leu-105,
Val-108, Met-124, and Ile-125) form close contacts with the
aromatic side chain of Trp-292 from ER(287–305) (Fig. 2C).
Two lysine residues in ER- (Lys-299 and Lys-303) form salt
bridges with Glu-84 and Glu-87 in CaM.
TheCaMLobes Bind ER- in Cell Lysates—Analysis was con-
ducted to determine whether CaM-N and CaM-C could bind
endogenous ER- in a normal cellmilieu. To evaluate this inter-
action, we wanted to transfect cells with the individual lobes of
CaM and examine ER- binding. Although expression of intact
full-length CaM in cells was readily achieved, we encountered
considerable difficulty expressing the isolated lobes of CaM in
mammalian cells. After numerous attempts with several differ-
ent plasmids that express the N- or C-terminal half of CaM,
we were eventually successful with GFP-tagged constructs. We
generated GFP-tagged constructs of full-length CaM and the
two halves; the N-terminal half, amino acids 1–74, and the
C-terminal half, amino acids 75–148. Transfection of HEK-293
or MCF-7 cells with each plasmid yielded clear, and reproduc-
ible, protein expression as detected with anti-GFP antibody
(Figs. 3A, 4C, 5C, and 6C). Each proteinmigrated to its expected
position on SDS-PAGE.
To examine binding, we transfected GFP-tagged CaM-F,
CaM-N, and CaM-C into HEK-293 cells, isolated the proteins
with GFP-Trap_A agarose, and then incubated them with
MCF-7 cell lysates. GFP-tagged full-length CaM bound to
endogenous ER- in MCF-7 cell lysates (Fig. 3A). These find-
CaM-induced Dimerization of ER-
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ings are congruent with our prior documentation that endoge-
nous ER- co-immunoprecipitates with endogenous untagged
CaM from MCF-7 human breast epithelial cells (11). Consist-
ent with the in vitro data generated with pure CaM-N, CaM-C,
and the fragment of ER- (287–305) (15), we observed that the
individual lobes of CaM could precipitate endogenous ER-
from cell lysates (Fig. 3A). Moreover, in keeping with the stoi-
chiometry data, the amount of ER- bound to CaM-F is con-
siderably greater than that bound to CaM-N or CaM-C. No
ER- is present in samples containing GFP alone (Fig. 3A), val-
idating the specificity of the interaction with the CaM con-
structs. Probing the blots for GFP showed similar amounts of
each CaM construct (Fig. 3A, lower panel). These data reveal
that the N- and C-halves of CaM independently bind ER- in
cell lysates.
To determine whether CaM-N and CaM-C are capable of
binding other targets, we examined IQGAP1, which contains
four IQ motifs that interact with CaM (17). We tagged
CaM-F, CaM-N, and CaM-C with GST, expressed the pro-
teins in Escherichia coli (Fig. 3B, lower panel) and incubated
each with equal amounts of MCF-7 cell lysate. GST-tagged
full-length CaM bound to IQGAP1 in cell lysates (Fig. 3B).
Similarly, CaM-N and CaM-C each bind to endogenous
IQGAP1. Thus, the individual lobes of CaM can bind to at
least two targets that have different modes of association
with CaM.
Individual Lobes of CaM Abrogate E2-stimulated Transcrip-
tion by ER-—If full-length CaM binds two molecules of ER-,
thus promoting receptor dimerization and facilitating ER-
transcriptional activity, one would anticipate that the indi-
vidual lobes of CaM would elicit a different effect. In this
situation, each lobe of CaM would bind to a separate mole-
cule of ER-, but the separate CaM lobes would not be able
to induce receptor dimerization and ER- transcriptional
FIGURE 1. NMR spectroscopy of CaM binding to ER(287–305). A, 15N-1H HSQC spectra of 15N-labeled full-length CaM (black), CaM-N (cyan), and CaM-C
(magenta) in the presence of unlabeled ER(287–305). B, constant time 13C-1H HSQC spectra of 13C-labeled full-length CaM (black), CaM-N (cyan), and CaM-C
(magenta) in the presence of unlabeled ER(287–305). The experimental conditions are defined under “Experimental Procedures” and were the same as
described previously (15).
CaM-induced Dimerization of ER-
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activity would therefore not be increased. The strategy we
adopted to test this hypothesis was to transfect cells with the
individual lobes of CaM and examine ER- function.
The effect of the CaM constructs on ER- function was eval-
uated by assessing the ability of ER- to activate selected endog-
enous estrogen responsive genes. E2 promotes an increase of
pS2 hnRNA in HEK-293 cells that were transfected with ER-
(Fig. 4A, left panel). (HEK-293 cells do not contain endogenous
ER- (data not shown).) Transfection of GFP-tagged full-
length CaM slightly enhanced the ability of E2 to stimulate pS2
RNA. By contrast, expression of either CaM-N or CaM-C abro-
gated the effect of E2 on the transcriptional activation by ER-
(Fig. 4A, right panel). To extend these findings, we examined
the effect of CaMon the ability of ER- to activate progesterone
receptor (PR), which is another endogenous estrogen-respon-
sive gene. Analysis showed that either CaM-N or CaM-C
blocked the increase in PR elicited by E2 (Fig. 4B). Western
FIGURE 2. Structures of CaMER- complexes. A, NMR structure of full-length
CaM (dark blue) bound to two molecules of ER(287–305) (orange). The atomic
coordinatesweredeposited into theProteinDataBank (PDBaccessionno.5T0X).
Previous NMR structures of CaM-N (2LLO, cyan) and CaM-C (2LLQ,magenta) are
overlaid on the full-lengthCaM structure for comparison. BoundCa2 are yellow
spheres. The flexible interdomain linker (residues 74–82) forms an extended
main chain conformation depicted by a blue line. B and C, exposed hydrophobic
side chain atoms of CaM N-lobe (highlighted cyan in panel B) and C-lobe (high-
lightedmagenta in panel C) interact with side chain atoms of key ER- residues
(orange) shown as sticks. Hydrophobic side chain atoms in ER- (Trp-292) form
detailed contacts with each lobe of CaM, and basic side chains in ER- (Lys-299
and Lys-303) form salt bridgeswith Glu-14 (N-lobe) andGlu-84 (C-lobe) of CaM.
TABLE 1
Structure statistics for NMR structures of CaM bound to ER(287–305)
NMR restraints
Short range NOEs for ER peptides 30
Dihedral angles 79
H-bonds 66
Total intermolecular NOEs 96
1DHN RDC 76
Ramachandran plot
Most favored region (%) 80.5
Allowed region (%) 18.0
Disallowed region (%) 1.5
Root mean squared deviation from average structure (Å)
All backbone atoms
0.59
FIGURE 3. Binding of the CaM constructs to ER- and IQGAP1. A, HEK-293
cells were transfected with GFP-tagged CaM-F (F), CaM-N (N), or CaM-C (C) or
GFP alone (as control). GFP-tagged proteins were isolated with GFP-Trap_A
agarose as described under “Experimental Procedures,” then incubated with
equal amounts of protein lysate fromMCF-7 cells. An aliquot of MCF-7 lysate
that was not incubated with GFP-CaM or GFP was processed in parallel
(Lysate). Proteinswere resolvedby SDS-PAGE andWestern blotswere probed
with anti-ER- (upper panel) and anti-GFP (lower panel) antibodies. Data are
representative of 3 independent experiments. B, equal amounts of protein
lysate from MCF-7 cells were incubated with GST-tagged CaM-F (F), CaM-N
(N), or CaM-C (C) or GST alone (control). Complexes were isolated with gluta-
thione-Sepharose. An aliquot of lysate was processed in parallel (Lysate). Pro-
teinswere resolvedby SDS-PAGEand thegelwas cut at60 kDa. The top part
of the gel was transferred to PVDF, whereas the lower part was stained with
Coomassie Blue (lower panel). PVDF membranes were probed with anti-IQ-
GAP1 antibodies (upper panel). Data are representative of 2 independent
experiments.
CaM-induced Dimerization of ER-
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blotting of protein lysates confirmed that the cells expressed
equivalent amounts of each CaM construct and had the same
level of ER- (Fig. 4C).
To determinewhether the expression ofGFP-taggedCaM-N
or CaM-C can interfere with E2 stimulation of endogenous
ER-, MCF-7 were transfected with these constructs and tran-
scription of pS2 and PR hnRNA was examined by quantitative
RT-PCR. E2 stimulated transcription of pS2 by ER- inMCF-7
cells transfected with GFP-tagged CaM-F (Fig. 5A). Analogous
to the observations in HEK-293 cells, E2 was unable to increase
pS2 transcription in MCF-7 cells transfected with CaM-N or
CaM-C. Similarly, the ability of E2 to increase PR in MCF-7
cells was abrogated in the presence of CaM-N or CaM-C (Fig.
5B). The level of expression of each CaM construct was equiv-
alent (Fig. 5C).
To ascertain whether the individual lobes of CaM could
interfere with the effects of full-length CaM, we co-transfected
full-length CaM with either CaM-N or CaM-C and examined
E2-stimulated transcriptional activation. In HEK-293 cells
transfected with full-length CaM and empty vector, E2 signifi-
cantly stimulated the transcriptional activation of pS2 RNA
(Fig. 6A). However, when cells were co-transfected with full-
length CaM and CaM-N, E2 was unable to promote transcrip-
tional activation of pS2 RNA. Similarly, transfecting CaM-C
together with full-length CaM into cells completely prevented
FIGURE 4. CaM alters ER- function. A, HEK-293 cells were transiently trans-
fectedwith both ER- and GFP-tagged CaM-F, CaM-N, CaM-C, or pEGFP (Vec-
tor). Cells were cultured in phenol red-free medium for 24 h, then vehicle
(EtOH, blue bars) or 100 nM E2 (red bars) was added to the medium. After
incubation for 6 h, total RNA was isolated and quantitative RT-PCR analysis
was performed to measure pS2 hnRNA. The amount of RNA in each sample
was corrected for -actin RNA in the same sample. Vehicle-treated cells were
set as 1. The data represent the mean S.E. (error bars) of two independent
experiments for vector and CaM-F (left panel) or three or four independent
experiments for CaM-F, CaM-N, and CaM-C (right panel). Each condition was
measured in triplicate.B, HEK-293 cellswere transiently transfectedwithboth
ER- and either pEGFP (Vector) or the GFP-tagged CaM plasmids. Following
cell culture and E2 stimulation, performed as described for panel A, PR hnRNA
was measured by quantitative RT-PCR. Samples were analyzed as described
for pS2. The data represent the mean S.E. (error bars) of two independent
experiments for vector and CaM-F (left panel) or three or four independent
experiments for CaM-F, CaM-N, and CaM-C (right panel). Each condition was
measured in triplicate. *, p 0.05; **, p 0.01. C, cells, transfected as outlined
above, were lysed and equal amounts of protein lysate were resolved by
Western blotting. Blots were probed with antibodies to ER- (upper panel)
and GFP (lower panel). A representative experiment of 2 is shown.
FIGURE 5. Individual lobes of CaM impair E2 stimulation of endogenous
ER- transcription. A and B, MCF-7 cells were transiently transfected with
either GFP-tagged CaM-F, CaM-N, or CaM-C. Cells were cultured in phenol
red-freemedium for 24h, then vehicle (EtOH,blue bars) or 100nME2 (red bars)
was added to themedium.After incubation for 6h, total RNAwas isolatedand
quantitative RT-PCR analysis was performed to measure pS2 (panel A) or PR
(panel B) hnRNA. The amount of RNA in each samplewas corrected for-actin
RNA in the same sample. Vehicle-treated cells were set as 1. The data repre-
sent the mean S.E. (error bars) of an experiment performed in triplicate. C,
MCF-7 cells, transfected as outlined above, were lysed and equal amounts of
protein lysate were resolved by Western blotting. Blots were probed with
antibodies to ER- (upper panel) and GFP (lower panel). All data are represen-
tative of at least 3 independent experiments.
CaM-induced Dimerization of ER-
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E2 from enhancing transcriptional activation of pS2 RNA
(Fig. 6A). Essentially identical results were observed with PR.
Expression of either CaM-N or CaM-C with full-length CaM
abrogated the transcriptional activation of PR induced by E2
(Fig. 6B). These findings suggest that the individual lobes of
CaM competitively inhibit full-length CaM. Western blotting
of cell lysates verified the expression of equivalent levels of
ER- and the CaM constructs (Fig. 6C). Collectively these data
indicate that the separate lobes of CaMare able to bind to ER-,
but they are unable to induce dimerization and promote acti-
vation of the receptor. It is noteworthy that binding of a single
lobe of CaM, either the N- or C-lobe, to ER- completely pre-
vents E2 from stimulating transcriptional activation of the tar-
get genes we investigated.
Discussion
Previously, we solved the NMR structures of individual CaM
lobes (CaM-N andCaM-C) each ofwhich binds to the same site
on ER- (15). We showed that full-length CaM binds to two
ER- molecules, whereas CaM-N and CaM-C each binds to
only one (15). On the basis of this earlier structural analysis, we
proposed that each lobe of CaM binds to a separate ER-mol-
ecule. In the current study, we now present the structure of
full-lengthCaMbound to twoER-peptides (Fig. 2). The struc-
ture reveals that each CaM lobe makes contact with the same
residues of ER- (residues 292, 299, and 303 in Fig. 2B). Fur-
thermore, the structure of both lobes in full-length CaM
(bound to two ER-) looks identical to the previous structures
of the individual lobes each bound to a single ER- peptide (15).
This structural independence of the two CaM lobes is consis-
tent with our binding studies (15) that indicate each CaM lobe
binds to ER- with nearly the same binding affinity as full-
length CaM. Finally, the structure of full-length CaM bound to
two molecules of ER- indicates a lack of structural contacts
between the CaM lobes, which argues against allosteric confor-
mational changes suggested by Carlier et al. (16). We conclude
that one molecule of CaM connects two molecules of ER-,
which stabilizes its dimer structure and promotes transcrip-
tional activation.
Our in vivo experiments provide biological data to support
themodel derived from the structural analysis. Prior work from
our laboratory (11) andothers (10, 12, 18), established thatCaM
interacts with ER- in vitro and in cells. Binding of CaM mod-
ulates both ER- degradation (10, 11, 13) and E2-stimulated
transcriptional activity of ER- (14). Interestingly, CaM is
required for the formation of the ER-ERE complex and for
activation of an estrogen responsive promotor (19). We previ-
ously generated an ER- construct in which Ile-298 and Lys-
299 are mutated, rendering the receptor unable to bind CaM
(14). E2 failed to stimulate transcriptional activation of this
mutant ER-. Moreover, blocking CaM function in the nucleus
ofMCF-7 cells by transfecting a targeted specific CaM inhibitor
peptide abrogated E2-induced transcriptional activation (9).
Collectively, these data strongly suggest that an interaction
between CaM and ER- in the nucleus is required for E2 to
stimulate transcriptional activation.
Consistent with these prior observations, we show here that
overexpression of full-length CaM slightly, albeit not signifi-
cantly, enhanced by 25% E2-induced transcriptional activation
of two endogenous estrogen-responsive genes, namely pS2 and
PR. The relatively small increase in E2-induced transcriptional
activation is most likely due to the high concentrations of
endogenous CaM in cells, which is 106 to 105 M, with even
higher concentrations in rapidly growing cells (8). By contrast,
expression of the separate lobes of CaM in cells abrogated the
FIGURE 6. Individual lobes of CaM abrogate E2-stimulated transcrip-
tional activation by ER-. A, HEK-293 cells were transiently transfectedwith
both ER- and pEGFP-CaM-F as well as pEGFP (vector), pEGFP-CaM-N, or
pEGFP-CaM-C. Cells were cultured in phenol red-free medium for 24 h, then
vehicle (EtOH, blue bars) or 100 nM E2 (red bars) was added to the medium.
After incubation for 6 h, total RNAwas isolated and quantitative RT-PCR anal-
ysis was performed tomeasure pS2 hnRNA. The amount of RNA in each sam-
ple was corrected for -actin RNA in the same sample. Vehicle-treated cells
were set as 1. The data represent the mean S.E. (error bars) of six indepen-
dent experiments, each performed in triplicate. B, HEK-293 cells were trans-
fected and stimulated with E2 as described for panel A. PR hnRNA was mea-
sured by quantitative RT-PCR. Samples were analyzed as described for pS2.
The data represent the mean  S.E. (error bars) of six independent experi-
ments, each performed in triplicate. C, cells, transfected as outlined above,
were lysed and equal amounts of protein lysate were resolved by Western
blotting. Blots were probed with antibodies to ER- (upper panel) and GFP
(lower panel). A representative experiment of 4 is shown. **, p 0.005.
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ability of E2 to stimulate ER- transcriptional activity. Amodel
illustrates how CaM regulates dimerization and activation of
ER- (Fig. 7). E2 binding induces dimerization of ER- and
translocation to the nucleus.Association ofCa2/CaMwith the
E2-boundER- enables the receptor to activate transcription of
target genes (Fig. 7). Note that CaM can stimulate ER-
dimerization in the absence of E2.When ER- is bound to only
one lobe of CaM instead of the full-length protein, CaM-in-
duced dimerization of ER- cannot occur and E2 is unable to
promote transcription. Thus, binding of both E2 and CaM to
ER- is required for it to maximally activate transcription
(Fig. 7).
The molecular mechanism by which the individual lobes of
CaM abrogate E2-stimulated transcriptional activation by
ER- is unknown. There are several possible explanations.
First, binding of CaM-N or CaM-C to ER-may prevent recep-
tor dimerization, which is necessary for transcriptional activa-
tion (2). The NMR structural data presented in this article
strongly support this mechanism. Second, binding to one lobe
of CaM may sterically block the interaction of ER- with co-
regulatory proteins, particularly co-activators, which modulate
transcriptional activation (20). Third, the ER-CaM-N or
ER-CaM-C complex may bind co-repressors rather than the
co-activators, which bind to ER-CaM (full-length). It is
known that the shape of the ligandER- complex influences
the specific co-regulators that are recruited (2). The compo-
nents of the complex influence receptor activity, which acti-
vates or represses gene transcription. Fourth, ER- may be
titrated away from other co-regulators by the isolated CaM
lobes. Fifth, the ER-CaM-N or ER-CaM-C complexes may
be unable to translocate to the nucleus where transcription is
activated. These mechanisms are not mutually exclusive and
more than one may account for our data.
Regardless of the molecular mechanism, our observations
elucidate the structure and biological function of the interac-
tion between ER- and CaM. It is estimated that 70% of breast
malignancies are ER- positive and therefore agents that sup-
press receptor function or E2 synthesis are used for therapy
(21). Antagonism of ER- with tamoxifen is the most widely
used treatment for patients with breast carcinoma. Our struc-
ture and functional data suggest that altering the association of
CaMwith ER- is a conceptually appealing therapeutic option.
Consistent with this premise, published studies reveal that
CaM antagonists attenuate the growth of breast cancer cell
lines (22–24) and enhance antiestrogen therapy (25–27). It is
possible that development of specifically targeted small mole-
cules that selectively disrupt the CaM/ER- interactionmay be
useful in the treatment of breast carcinoma and other ER--de-
pendent malignancies.
Experimental Procedures
Materials—HEK-293 cells and MCF-7 breast epithelial cells
were obtained from the American Type Culture Collection. All
reagents for tissue culture were bought from Invitrogen. PVDF
membranes were purchased fromMillipore Corporation. Anti-
bodies used in this study are listed in Table 2. Blocking buffer
(927-50000) and infrared dye-conjugated (IRDye) antibodies,
both goat anti-mouse IRDye 680LT (926–68020) and goat
anti-rabbit IRDye 800CW (926–32211) were obtained from
LI-COR Biosciences.
Construction of GFP-CaM and GST-CaM—The PCR prod-
ucts of full-length CaM (CaM-F), the N-terminal half (CaM-N,
amino acids 1–74), and the C-terminal half (CaM-C, amino
acids 75–148) of calmodulin were made using pDONR223-
CaM1 as template. Primerswere as follows: for CaM-F, forward
primer, 5-CGGGATCCGCTGATCAGCTGACCGAAGAA-
CAG-3 and reverse primer, 5-GCTCTAGACTCGAGTCA-
TTTTGCAGTCATCATCTGTACGAATTC-3; for CaM-N,
forward primer, 5-CGGGATCCGCTGATCAGCTGAC-
CGAAGAACAG-3 and reverse primer, 5-CCGGA-
ATTCTCTAGATCAATCTTTCATTTTTCTAGCCATCA-
TAG-3; and for CaM-C, forward primer, 5-CGGGATCC-
ACAGATAGTGAAGAAGAAATCCG-3 and reverse primer,
5-GCTCTAGACTCGAGTCATTTTGCAGTCATCATCT-
GTACGAATTC-3. The PCR products of each CaM construct
were digested with BamHI and XhoI. To generate GFP-CaM,
PCR products were inserted into pEGFP-C1 at BglII and SalI
sites. GST-CaM constructs were generated by inserting PCR
products into pGEX-4T-1 at BamHI and XhoI sites. The
sequences of all plasmids were verified by DNA sequencing.
Plasmids were purified with QIAprep Spin Mini Prep Kit
(Qiagen).
Cell Culture and Transfection—Cells were grown in DMEM
supplementedwith 10%FBS. Cells were transfected using Lipo-
fectamine 2000 (Invitrogen) according to the manufacturer’s
instructions.
FIGURE 7.Model of the regulationof ER-dimerization and transcription
by CaM. The N- and C-lobes of CaM are shown in pale blue (CaM-N) and pink
(CaM-C), respectively. Estrogen (E2) induces dimerization of ER-. Full-length
CaM (CaM-F) promotes ER- dimerization independently of E2. In contrast,
the individual lobes of CaM block ER- dimerization, thereby preventing
E2-stimulated transcriptional activation by ER-. Both E2 and Ca2/CaM are
required for maximal activation of transcription.
TABLE 2
Antibodies used in this study
Protein
detected Reference
Dilution for
immunoblots
ER- Santa Cruz sc-543 1:1000
ER- Cell Signaling Technology 8644 1:1000
Calmodulin Mouse monoclonal (39) 1:1000
GFP Santa Cruz sc-8334 1:1000
GFP Santa Cruz sc-9996 1:1000
Myc Millipore 06–549 1:1000
IQGAP1 Rabbit antiserum (28) 1:1000
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Preparation of GST Fusion Proteins—GST-CaM-F, GST-
CaM-N, and GST-CaM-C were expressed in E. coli and puri-
fied by glutathione-Sepharose chromatography, essentially as
described previously (28). All fusion proteins migrated to the
expected position on SDS-PAGE. Proteins were at least 90%
pure by Coomassie staining.
Binding Analysis—The binding of the CaM constructs to
endogenous ER- in MCF-7 lysates was evaluated. First, GFP-
tagged CaM-F, CaM-N, or CaM-C (or GFP alone) were trans-
fected into HEK-293 cells. Cells were cultured at 37 °C for 3
days, then lysed with 500 l of Buffer A (50 mM Tris-HCl, pH
7.4, 150 mM NaCl, and 1% Triton X-100) containing 1 mM
EGTA, 1 Protease&Phosphatase InhibitorMixture (Thermo
Scientific), and 1 mM PMSF. GFP was immunoprecipitated
with GFP-Trap_A (anti-GFP VHH conjugated to agarose,
ChromoTek) for 3 h at 4 °C, then washed 3 times with Buffer A
containing 1 mM EGTA. MCF-7 cells were lysed with Buffer A
containing 1 mM CaCl2, 1 mM PMSF, and 1 Protease & Phos-
phatase Inhibit Mixture. Equal amounts of MCF-7 protein
lysate were incubated for 3 h at 4 °C with the GFP-tagged pro-
teins on agarose beads. After 5 washes with Buffer A containing
1 mM CaCl2, samples were resolved by SDS-PAGE (29) and
transferred to PVDF. The membrane was blocked with Block-
ing Buffer (LI-COR) for 1 h at 22 °C, probed overnight at 4 °C
with anti-ER- polyclonal antibodies, then incubated for 1 h
with IRDye-conjugated anti-rabbit antibody. Antigen-antibody
complexes were detected using the Odyssey Imaging System
(LI-COR). GFP-tagged proteins were detected by probing the
membrane with anti-GFP monoclonal antibody, followed by
IRDye-conjugated anti-mouse antibody and detected with the
Odyssey Imaging System.
Binding of CaM-F, CaM-N, and CaM-C to endogenous
IQGAP1 was also performed. MCF-7 cells were lysed with 500
l of Buffer A containing 2mMEDTA, 1Protease&Phospha-
tase Inhibitor Mixture, and 1 mM PMSF, then pre-cleared by
rotating for 1 h at 4 °Cwith glutathione-Sepharose beads. Equal
amounts of protein lysate were incubated with 40 l of GST-
CaM-F, GST-CaM-N, GST-CaM-C, or GST (control). All GST
fusion proteins were bound to glutathione-Sepharose beads
prior to adding lysate. After rotating at 4 °C for 3 h, samples
were washed 5 times with Buffer A and resolved by SDS-PAGE
(29). The gel was cut slightly above the 50-kDa molecular mass
marker into twopieces. The lower portion of the gel was stained
with Coomassie Blue. The upper portion of the gel was trans-
ferred to PVDF and processed essentially as described for ER-,
except the blots were probed with anti-IQGAP1 antibodies.
Quantitative RT-PCR—HEK-293 cells were cultured in phe-
nol red-free medium with 10% charcoal-stripped fetal bovine
serum (FBS), and transfected with pcDNA3-myc-ER- and
pEGFP-CaM-F, pEGFP-CaM-N, pEGFP-CaM-C, or pEGFP
(vector). Where indicated, cells were transfected with both
pcDNA3-myc-ER- and pEGFP-CaM-F, as well as pEGFP-
CaM-N, pEGFP-CaM-C, or pEGFP. The next day, the medium
was replaced with fresh FBS-free medium. After 2 days, vehicle
(EtOH) or E2 (to obtain a final concentration of 100 nM) were
added to the medium. Following a 6-h incubation, total RNA
was isolated from the cells using TRIzol (Invitrogen). 2 g of
RNA was reverse transcribed to cDNA using a High Capacity
cDNA Reverse Transcriptase kit (Applied Biosystems) accord-
ing to themanufacturer’s instructions. RT-PCRwas performed
on a StepOnePlus Real Time PCR system (Applied Biosystems)
using SYBR Green PCR master mix (Applied Biosystems) and
200 nM forward and reverse primers. The primers used were:
for PR, forward primer, 5-CCTCGGACACCTTGCCTGAA-
3, reverse primer, 5-CGCCAACAGAGTGTCCAAGAC-3;
for pS2, forward primer, 5-TTGGAGAAGGAAGCTG-
GATGG-3, reverse primer, 5-ACCACAATTCTGTCT-
TTCACGG-3; and for -actin, forward primer, 5-TGCGT-
GACATTAAGGAGAAG-3, reverse primer, 5-GCTCG-
TAGCTCTTCTCCA-3. RT-PCR enzyme activation was initi-
ated for 10 min at 95 °C, then amplified by 40 cycles (15 s at
95 °C and 1min at 60 °C). All samples were assayed in triplicate
and -actin was used as an internal control. Results were ana-
lyzed using the 		CT method with StepOnePlus software
(Applied Biosystems). RT-PCR with MCF-7 cells was per-
formed essentially as described for HEK-293 cells, except the
transfection with pcDNA3-myc-ER- was omitted as MCF-7
cells have endogenous ER-.
NMR Sample Preparation—NMR samples of isotopically
labeled CaM bound to ER(287–305) were prepared as
described previously (15). Purified CaM (3.5 mg) was initially
dissolved in 10ml of NMR buffer (20mMTris-d11, 5 mMCaCl2,
50 mM NaCl, 8% D2O, pH 7.0) and then added to 2 eq of
ER(287–305). The CaMER complex was incubated at room
temperature for 1 h, and concentrated to 0.4 ml using Amicon
Ultra Centrifugal FiltersUltracel-3K (Millipore, UFC900324, 3
kDa cut-off).
NMR Spectroscopy—All NMR experiments were carried out
at 310K and performed using BrukerAvance III 800MHz spec-
trometer equipped with a four-channel interface and triple-
resonance cryoprobe (TCI). Two-dimensional NMR experi-
ments, 15N-1H HSQC (and constant-time 13C-1H HSQC)
spectra were recorded on a sample of 15N-labeled (13C-labeled)
CaM in the presence of unlabeled ER(287–305). All three-di-
mensional NMR experiments for assigning backbone and side
chain resonances were recorded on a double labeled sample
(15N,13C-labeled CaM bound to unlabeled ER(287–305) as
described previously (15). NMR distance restraints were
obtained as described (15). NMR data were processed using
NMRPipe (30) and analyzed with SPARKY (T. D. Goddard and
D. G. Kneller, University of California at San Francisco).
Structure Calculation—The NMR structure of full-length
CaM bound to ER(287–305) was calculated using NMR-de-
rived distance restraints and residual dipolar couplings as
described previously (15, 31–33). The structure of ER(287–
305) bound to full-length CaM was verified to form an -helix
based onNOEdistance restraints (HN-HN connectivity), chem-
ical shift index (34), and circular dichroism analysis as
described previously (15). TheNMR-derived structures ofCaM
and ER(287–305) were then used as input for molecular dock-
ing within HADDOCK (35–38) using intermolecular NOE
restraints and residual dipolar coupling data as described pre-
viously (15). The structure of ER(287–305) in the docking cal-
culation was set as full flexible, and side chain atoms of CaM
that exhibited intermolecular NOEs with ER(287–305) were
allowed to move during simulated annealing. The final struc-
CaM-induced Dimerization of ER-
MARCH 17, 2017•VOLUME 292•NUMBER 11 JOURNAL OF BIOLOGICAL CHEMISTRY 4621
 by guest on O
ctober 2, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
tures were further refined by including a final water refinement
step.
Miscellaneous Methods—Statistical analysis was performed
by Student’s t test with Prism 6 (GraphPad). Protein concentra-
tions were measured with the DC Protein Assay (Bio-Rad).
Author Contributions—J. B. A. and D. B. S. designed the study. Z. L.,
Y. Z., and A. C. H. conducted experiments. Z. L., Y. Z., A. C. H.,
J. B. A., andD. B. S. analyzed data. J. B. A. andD. B. S. wrote theman-
uscript. All authors reviewed the results and approved the final ver-
sion of the manuscript.
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